GSA Capital Partners’s Spero Therapeutics SPRO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-28,319	Closed	-$49K	–	1999
2024 Q1	$49K	Buy	+28,319	New	+$49K	﹤0.01%	1535
2022 Q3	–	Sell	-10,450	Closed	-$8K	–	1836
2022 Q2	$8K	Sell	10,450 -15,466	-60%	-$11.8K	﹤0.01%	1333
2022 Q1	$225K	Buy	+25,916	New	+$225K	0.03%	1104